The management of benign non-infective pleural effusions

The evidence base concerning the management of benign pleural effusions has lagged behind that of malignant pleural effusions in which recent randomised trials are now informing current clinical practice and international guidelines. The causes of benign pleural effusions are broad, heterogenous and...

Full description

Bibliographic Details
Main Authors: Oliver J. Bintcliffe, Gary Y.C. Lee, Najib M. Rahman, Nick A. Maskell
Format: Article
Language:English
Published: European Respiratory Society 2016-09-01
Series:European Respiratory Review
Online Access:http://err.ersjournals.com/content/25/141/303.full
id doaj-a76711fea7144f7b8a3fb211c510af53
record_format Article
spelling doaj-a76711fea7144f7b8a3fb211c510af532020-11-24T21:50:45ZengEuropean Respiratory SocietyEuropean Respiratory Review0905-91801600-06172016-09-012514130331610.1183/16000617.0026-20160026-2016The management of benign non-infective pleural effusionsOliver J. Bintcliffe0Gary Y.C. Lee1Najib M. Rahman2Nick A. Maskell3 Academic Respiratory Unit, School of Clinical Sciences, University of Bristol, Bristol, UK Centre for Asthma, Allergy & Respiratory Research, School of Medicine & Pharmacology, University of Western Australia, Perth, Australia Oxford Centre for Respiratory Medicine and Oxford NIHR Biomedical Research Centre, Churchill Hospital, Oxford, UK Academic Respiratory Unit, School of Clinical Sciences, University of Bristol, Bristol, UK The evidence base concerning the management of benign pleural effusions has lagged behind that of malignant pleural effusions in which recent randomised trials are now informing current clinical practice and international guidelines. The causes of benign pleural effusions are broad, heterogenous and patients may benefit from individualised management targeted at both treating the underlying disease process and direct management of the fluid. Pleural effusions are very common in a number of non-malignant pathologies, such as decompensated heart failure, and following coronary artery bypass grafting. Pleural fluid analysis forms an important basis of the diagnostic evaluation, and more specific assays and imaging modalities are helpful in specific subpopulations. Options for management beyond treatment of the underlying disorder, whenever possible, include therapeutically aspirating the fluid, talc pleurodesis and insertion of an indwelling pleural catheter. Randomised trials will inform clinicians in the future as to the risks and benefits of these options providing a guide as to how best to manage patient symptoms in this challenging clinical setting.http://err.ersjournals.com/content/25/141/303.full
collection DOAJ
language English
format Article
sources DOAJ
author Oliver J. Bintcliffe
Gary Y.C. Lee
Najib M. Rahman
Nick A. Maskell
spellingShingle Oliver J. Bintcliffe
Gary Y.C. Lee
Najib M. Rahman
Nick A. Maskell
The management of benign non-infective pleural effusions
European Respiratory Review
author_facet Oliver J. Bintcliffe
Gary Y.C. Lee
Najib M. Rahman
Nick A. Maskell
author_sort Oliver J. Bintcliffe
title The management of benign non-infective pleural effusions
title_short The management of benign non-infective pleural effusions
title_full The management of benign non-infective pleural effusions
title_fullStr The management of benign non-infective pleural effusions
title_full_unstemmed The management of benign non-infective pleural effusions
title_sort management of benign non-infective pleural effusions
publisher European Respiratory Society
series European Respiratory Review
issn 0905-9180
1600-0617
publishDate 2016-09-01
description The evidence base concerning the management of benign pleural effusions has lagged behind that of malignant pleural effusions in which recent randomised trials are now informing current clinical practice and international guidelines. The causes of benign pleural effusions are broad, heterogenous and patients may benefit from individualised management targeted at both treating the underlying disease process and direct management of the fluid. Pleural effusions are very common in a number of non-malignant pathologies, such as decompensated heart failure, and following coronary artery bypass grafting. Pleural fluid analysis forms an important basis of the diagnostic evaluation, and more specific assays and imaging modalities are helpful in specific subpopulations. Options for management beyond treatment of the underlying disorder, whenever possible, include therapeutically aspirating the fluid, talc pleurodesis and insertion of an indwelling pleural catheter. Randomised trials will inform clinicians in the future as to the risks and benefits of these options providing a guide as to how best to manage patient symptoms in this challenging clinical setting.
url http://err.ersjournals.com/content/25/141/303.full
work_keys_str_mv AT oliverjbintcliffe themanagementofbenignnoninfectivepleuraleffusions
AT garyyclee themanagementofbenignnoninfectivepleuraleffusions
AT najibmrahman themanagementofbenignnoninfectivepleuraleffusions
AT nickamaskell themanagementofbenignnoninfectivepleuraleffusions
AT oliverjbintcliffe managementofbenignnoninfectivepleuraleffusions
AT garyyclee managementofbenignnoninfectivepleuraleffusions
AT najibmrahman managementofbenignnoninfectivepleuraleffusions
AT nickamaskell managementofbenignnoninfectivepleuraleffusions
_version_ 1725881797144739840